Skip to main content
Log in

Giant cavernous haemangioma with Kasabach-Merritt syndrome: a case report and review

  • Original Paper
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract.

We report the case of a 4-month-old boy presenting with a giant cutaneous haemangioma complicated by Kasabach-Merritt syndrome (KMS) with severe thrombocytopenia. After poor response to corticosteroid therapy and subsequent treatment with interferon alpha-2a, radiotherapy led to tumour regression and resolution of the disseminated intravascular coagulopathy over a 14-month period of follow up. Whereas the various available treatment options are reviewed and discussed in this article, the therapy of choice should be chosen individually. Conclusion: to date prospective randomised and controlled trials are required to investigate the optimal management of patients with Kasabach-Merritt syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tanja Frevel.

Additional information

Electronic Publication

Rights and permissions

Reprints and permissions

About this article

Cite this article

Frevel, T., Rabe, H., Ückert, F. et al. Giant cavernous haemangioma with Kasabach-Merritt syndrome: a case report and review. Eur J Pediatr 161, 243–246 (2002). https://doi.org/10.1007/s00431-002-0953-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-002-0953-5

Navigation